Cargando…
Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019
IMPORTANCE: In bacterial sepsis, CD14 and its N-terminal fragment (soluble CD14 subtype, “Presepsin”) have been characterized as markers of innate immune responses and emerging evidence has linked both to coronavirus disease 2019 pathophysiology. OBJECTIVES: Our aim was to determine the relationship...
Autores principales: | Mabrey, F. Linzee, Morrell, Eric D., Bhatraju, Pavan K., Sathe, Neha A., Sakr, Sana S., Sahi, Sharon K., West, T. Eoin, Mikacenic, Carmen, Wurfel, Mark M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663850/ https://www.ncbi.nlm.nih.gov/pubmed/34909698 http://dx.doi.org/10.1097/CCE.0000000000000591 |
Ejemplares similares
-
Plasma Interleukin-6 Predicts Clinical Decline After Completion of Dexamethasone Therapy in Severe COVID-19
por: Mabrey, F. Linzee, et al.
Publicado: (2022) -
Biomarker Signatures of Severe Acute Kidney Injury in a Critically Ill Cohort of COVID-19 and Non-COVID-19 Acute Respiratory Illness
por: Sathe, Neha A., et al.
Publicado: (2023) -
Evaluating construct validity of computable acute respiratory distress syndrome definitions in adults hospitalized with COVID-19: an electronic health records based approach
por: Sathe, Neha A., et al.
Publicado: (2023) -
TLRs in COVID-19: How they drive immunopathology and the rationale for modulation
por: Mabrey, F. Linzee, et al.
Publicado: (2021) -
Presence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 on Admission Is Associated With Decreased Mortality in COVID-19 Critical Illness
por: Mabrey, F. Linzee, et al.
Publicado: (2022)